Aesthetic Injection Safety: 7 Essential Habits for Practitioners

Safe aesthetic injecting comes down to seven habits:

1. Screen every patient.
2. Get truly informed consent.
3. Buy product only from authorized sources.
4. Know the anatomy you’re injecting into.
5. Use technique that limits intravascular risk.
6. Respect the specific warnings on neuromodulators.
7. Have a vascular emergency plan in place before you ever need it.

Serious complications are rare, but several are permanent, which is why each habit matters.

1. Screen every patient before you treat

Take a full history at every new-patient visit, and update it at every return visit. Cover:

• allergies and prior reactions to fillers, neuromodulators, or lidocaine
• current medications and supplements, especially anything that raises bleeding risk
• prior aesthetic treatments, including what product was placed where
• active skin infection or inflammation at the treatment site
• neuromuscular conditions, which matter for neuromodulator treatment (see section 5)
• the patient’s goals, and whether they’re realistic

Take standardized baseline photos under consistent lighting. They document the starting point and protect you and the patient if a question comes up later.

2. Make informed consent specific

A consent form that says “risks include bruising and swelling” isn’t informed consent for filler.

The FDA identifies unintentional injection into a blood vessel as the most concerning risk of dermal fillers. It’s uncommon, but it can be serious and sometimes permanent, and reported complications include tissue necrosis, vision abnormalities including blindness, and stroke. Patients should hear that plainly, in the context of how rare it is. They should also hear the product-specific risks listed in the manufacturer’s labeling.

For neuromodulators, consent should cover the expected effects, the temporary nature of results, and the labeled risks, including eyelid or brow ptosis and the rare but serious possibility of spread of toxin effect.

3. Buy product only from authorized sources

This is the simplest safety step, and it’s non-negotiable.

In April 2024, the FDA warned that counterfeit Botox® had been found in multiple states, and linked it to hospitalizations. Symptoms included blurred or double vision, difficulty swallowing, shortness of breath, and weakness. The products appear to have been bought from unlicensed sources. Federal law requires providers to purchase prescription drugs only from authorized sources.

Before you open a vial or syringe, check the packaging, lot number, and expiration date. Record the lot number in the chart for every treatment.

4. Know the anatomy, especially the high-risk zones

Intravascular injection can happen anywhere on the face. The FDA’s review of the literature and adverse event reports found that blood vessel blockage was reported more often at certain sites: the glabella, in and around the nose, the forehead, and the periorbital region.

The FDA’s guidance to providers is direct:

• Don’t inject fillers without appropriate training.
• Know the anatomy at and around each injection site.
• Remember that vessel anatomy varies from patient to patient.

That variation is why textbook diagrams aren’t enough. It’s also why CATI teaches the vascular anatomy of the face in a cadaver lab before students inject a live model.

5. Use technique that limits intravascular risk

Published guidance emphasizes injection anatomy and plane, plus slow, low-pressure injection. Many injectors also keep the needle or cannula moving and deliver small amounts, to avoid placing a single large bolus inside a vessel.

On aspiration: don’t treat a negative aspiration as proof you’re safe. A 2022 review in Aesthetic Surgery Journal found that false negatives can happen for several reasons: the vessel collapses, the needle shifts during the maneuver, or filler blocks the needle and prevents a blood flash. Some clinical case series still see value in pre-injection aspiration, so the debate isn’t closed. The practical point stands either way: aspiration is at most one layer of protection, never a replacement for anatomy and technique.

6. Respect the neuromodulator warnings

Neuromodulators carry their own safety profile, and new injectors sometimes underestimate it.

Distant spread of toxin effect. The prescribing information for BOTOX® Cosmetic carries a boxed warning that the effects of all botulinum toxin products may spread from the injection site. Symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life-threatening, and deaths have been reported. At labeled cosmetic doses, the label reports no definitive serious adverse events of distant spread, but patients should still know to seek immediate care if they develop trouble swallowing, speaking, or breathing.

Units are not interchangeable. Potency units of BOTOX® Cosmetic can’t be compared to or converted into units of any other botulinum toxin product. Never assume a dose for one brand carries over to Dysport®, Xeomin®, Jeuveau®, or Daxxify®. Work from each product’s own labeling.

Hypersensitivity. Serious reactions, including anaphylaxis, have been reported. If one occurs, stop the injection and start appropriate medical therapy immediately.

7. Prepare for a vascular event before it happens

The time to plan for vascular occlusion is before you pick up a syringe, not after you see blanching.

Have a written protocol and an emergency kit in the room. For HA fillers, that means hyaluronidase on hand. A 2026 review in Aesthetic Plastic Surgery found that hyaluronidase remains the only intervention consistently associated with better outcomes. The best way to deliver it in cases involving the eye is still debated. Base your protocol on published consensus, such as the Aesthetic Surgery Journal consensus on minimizing the risk of hyaluronic acid embolic visual loss, and review it with your medical director.

Know the warning signs. Watch during and after injection for:

• blanching
• pain that’s disproportionate to the procedure
• mottled or dusky skin color
• delayed capillary refill

Treat any visual symptoms as an emergency. Published outpatient algorithms describe immediate in-office steps (including hyaluronidase and ocular massage) and early transfer for specialist and hospital care. Visual symptoms after filler are never a “watch and wait” situation.

Know the limits of hyaluronidase. It only dissolves HA fillers. The FDA notes that some filler materials may be difficult or impossible to remove.

Report adverse events. The FDA asks providers to report adverse events involving unintentional intravascular filler injection to MedWatch, its adverse event reporting program.

After the injection: monitor, document, follow up

• Keep the patient in clinic briefly after treatment and check for early signs of vascular compromise or reaction.
• Give written aftercare instructions, including which symptoms mean they should call you or seek emergency care.
• Document product, lot number, injection sites, volumes or units, and technique.
• Schedule follow-up, especially for new patients and new treatment areas.

How CATI teaches injection safety

Safety is built into how our courses run, not bolted on as one lecture.

• Didactic sessions cover mechanisms of action, dosing, facial assessment, and complication management.
• Cadaver workshops show the depth, muscle orientation, and vascular structures of the face.
• Live model day puts you on real patients under direct instructor supervision.
• Small groups mean instructors watch your angle, depth, and placement, and correct you in the moment.

If you’re returning to injecting after time away, our Refresher Course revisits technique and complication management.

What to do next

1. Audit your consent form. Does it name vascular occlusion, necrosis, and vision loss for filler?
2. Check where your product comes from, and start recording lot numbers if you don’t already.
3. Write a vascular occlusion protocol with your medical director, and stock the kit.
4. Build your anatomy foundation before you inject high-risk zones. Start with Foundations of Aesthetic Injections.

Frequently asked questions

Should I aspirate before injecting filler?
Aspiration is debated. Published reviews show negative aspiration can give false reassurance, so it should never replace anatomy knowledge and safe technique.

Can hyaluronidase reverse any filler?
No. It dissolves hyaluronic acid fillers only.

Which facial areas carry the highest risk of vascular occlusion?
FDA-reviewed reports most often involve the glabella, the nose, the forehead, and the area around the eyes. Vessels can be anywhere, though, and anatomy varies between patients.

Train with anatomy first

View upcoming courses, or call (860) 572-6868 or email registrar@coastalaesthetictraining.com with questions.

This article is for educational purposes for licensed healthcare professionals and is not a substitute for formal training, supervision, or your state’s scope-of-practice rules.